You have no items in your shopping cart.
Product Details
| Cat # +Size | A2177-100 |
|---|---|
| Size | 100 μg |
| Antibody Target | CD30 |
| Alternate Name | cAC10-vcMMAE, SGN 35, SGN-35, Ki-1, D1S166E, TNFRSF8 |
| Host | Human/Mouse chimeric |
| Antibody Type | Monoclonal |
| Isotype | IgG1, kappa |
| Immunogen | Human CD30 |
| Accession # | DB08870 |
| Appearance | Colorless liquid |
| Concentration | 1 mg/ml |
| Formulation | In PBS, pH 7.5 |
| Purification | Protein A purified |
| Species Reactivity | Human |
| Handling | The antibody solution should be gently mixed before use. |
| Storage Conditions | -80°C |
| Shipping Conditions | Gel Pack |
| USAGE | For Research Use Only! Not For Use in Humans. |
Details
The research-grade biosimilar is an antibody-drug conjugate that targets CD30. The conjugate consists of an Anti-CD30 human-mouse chimeric IgG1 antibody that is linked to a microtubule disrupting agent monomethyl auristatin E (MMAE) via a protease-cleavable linker. Upon internalization in the cell, the MMAE is detached from the antibody due to proteolytic cleavage. The MMAE then disrupts the microtubule network, which causes cell cycle arrest and results in apoptosis of tumorigenic cells. The original drug received approval from the FDA to treat adult patients with relapsed or refractory Hodgkin’s lymphoma and systemic anaplastic large cell lymphoma.
Why buy BioVision Products?
 |
 |
 |
 |
Innovation |
Affordability |
Global Presence |
Technical Support |
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways. |
BioVision is committed to providing the highest quality products at a competitive price. |
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery. |
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently. |
